Biohaven Pharma (BHVN) Tops Q1 EPS by 41c

Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.98), $0.41 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• ICICI Securities Starts Jain Resource Recycling (JAINREC:IN) at Buy (1)
• Dell’s earning report was bullish for Intel CPU demand, analyst says